I'm a buyer at under $3.10Is this thesis still good?http://ethicalequities.com.au/vocus-communications-is-a-good-long-term-investment-asx-voc/(i think so)
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling